Clinical Trials Browser

Phase 4 × INDUSTRY × Prostate Cancer Metastatic × Clear all

NCT02485691 2022-05-27

CARD

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT02074137 2016-06-02

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Phase 4 Completed

Prostate Cancer Metastatic